Gain Therapeutics Inc.

GANX

1 institutional investors and hedge funds own GANX, holding 566,130 shares worth $1.1M (latest 13F filings).

Advanced Chart

Who owns Gain Therapeutics Inc. stock?

Institutional holders of GANX — largest position first.

Super Fund	Position	Shares	Curr. Value	Port. %	Activity
DME Capital Management	Equity	566,130	$1,098,292	0.03%	0%

Ownership Statistics

Total Shares Held: 566,130

Total Value Reported: $1,098,292

Average Allocation per Portfolio 0.03%

Largest Single Portfolio Allocation: 0.03%

Largest Shareholder: DME Capital Management

Change in Total Shares Held (Q on Q): +0

Percentage Change in Shares Held (Q on Q): 0.00%

Number of Super Fund Holders: 1

Number of New Holders (Q on Q): 0

Number of Funds with Additions (Q on Q): 0

Number of Funds with Reductions (Q on Q): 0

Number of Funds Fully Divested (Q on Q): 0

Number of Funds with No Change (Q on Q): 1

Ownership Distribution

Loading chart…

Ownership History

Loading chart…

Company Profile

Fundamental Data

Gain Therapeutics Inc.

GANX

1 institutional investors and hedge funds own GANX, holding 566,130 shares worth $1.1M (latest 13F filings).

Advanced Chart

Who owns Gain Therapeutics Inc. stock?

Institutional holders of GANX — largest position first.

Super Fund	Position	Shares	Curr. Value	Port. %	Activity
DME Capital Management	Equity	566,130	$1,098,292	0.03%	0%

Ownership Statistics

Total Shares Held: 566,130

Total Value Reported: $1,098,292

Average Allocation per Portfolio 0.03%

Largest Single Portfolio Allocation: 0.03%

Largest Shareholder: DME Capital Management

Change in Total Shares Held (Q on Q): +0

Percentage Change in Shares Held (Q on Q): 0.00%

Number of Super Fund Holders: 1

Number of New Holders (Q on Q): 0

Number of Funds with Additions (Q on Q): 0

Number of Funds with Reductions (Q on Q): 0

Number of Funds Fully Divested (Q on Q): 0

Number of Funds with No Change (Q on Q): 1

Ownership Distribution

Loading chart…

Ownership History

Loading chart…